02.17.26 -- The Metaphoric Rise Of Outsourcing

Discover how high-speed isolator lines enable sterile, scalable manufacturing for complex biologics and injectables with unmatched efficiency and product integrity.

By leveraging cells equipped with an existing landing pad, we demonstrate how inducible expression can be efficiently achieved within just 4-6 weeks after donor plasmid creation.

Watch as our CGT experts explore the evolving landscape of viral vector manufacturing, overcoming production bottlenecks, and the strategies necessary to bring life-changing therapies to more patients.

International Society for Pharmaceutical Engineering members developed the guide to offer a risk-based framework for evaluating, implementing, and maintaining AI systems.

See two projects that focus on improving efficiency and productivity in biopharmaceutical manufacturing while reducing the cost of goods through process intensification.

This panel session features a decade-long story of partnership in bringing two life-changing gene therapies to market successfully.

Uncover how the evolution of T7 polymerase is optimizing in vitro transcription for RNA therapeutics. Learn to balance performance, cost, and supply to make smart choices for your xRNA manufacturing.

ATMPs challenge existing E&L practices in single-use manufacturing. Gain expert insight into regulatory gaps, risk management needs, and the urgency for tailored approaches.

Accelerate rAAV gene therapy manufacturing with unmatched speed, expertise, and scale—delivering clinical and commercial supply to help innovators reduce risk and achieve regulatory confidence.

Witness how NYBCe and CCS are transforming cell and gene therapy development with end-to-end CDMO solutions, advanced logistics, and a growing innovation hub in Louisville.

Cell therapies hold immense promise, but navigating the development process can be daunting. A strategic partner can bridge the gap between early-stage innovation and successful commercialization.